PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 18 filers reported holding PTC THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $8,206,000 | -3.5% | 8,000,000 | 0.0% | 0.66% | +2.5% |
Q4 2021 | $8,505,000 | +1.5% | 8,000,000 | 0.0% | 0.64% | -18.0% |
Q3 2021 | $8,383,000 | -4.1% | 8,000,000 | 0.0% | 0.79% | -16.0% |
Q2 2021 | $8,743,000 | -10.7% | 8,000,000 | -5.9% | 0.94% | -21.7% |
Q1 2021 | $9,796,000 | -10.6% | 8,500,000 | 0.0% | 1.20% | -2.0% |
Q4 2020 | $10,952,000 | +13.2% | 8,500,000 | 0.0% | 1.22% | +3.1% |
Q3 2020 | $9,674,000 | -16.9% | 8,500,000 | +84900.0% | 1.18% | -40.5% |
Q2 2020 | $11,641,000 | +249.0% | 10,000 | +233.3% | 1.99% | +296.2% |
Q2 2019 | $3,336,000 | – | 3,000 | – | 0.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 24,877,000 | $25,902,000 | 1.06% |
PFM Health Sciences, LP | 19,807,000 | $20,605,000 | 0.61% |
Partner Investment Management, L.P. | 193,000 | $201,000 | 0.34% |
DeepCurrents Investment Group LLC | 4,430,000 | $4,581,000 | 0.31% |
WOLVERINE ASSET MANAGEMENT LLC | 20,454,000 | $21,253,000 | 0.27% |
FARALLON CAPITAL MANAGEMENT LLC | 24,176,000 | $25,210,000 | 0.19% |
PALISADE CAPITAL MANAGEMENT, LP | 2,300,000 | $2,381,000 | 0.07% |
Verition Fund Management LLC | 1,415,000 | $1,472,000 | 0.04% |
CAPSTONE INVESTMENT ADVISORS, LLC | 4,298,000 | $4,470,000 | 0.03% |
LOOMIS SAYLES & CO L P | 248,482 | $8,404,000 | 0.02% |